Clinical trial
A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma
NCT00423306 is registered in ClinicalTrials.gov with Alaunos Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma
- Lead sponsor
- Alaunos Therapeutics
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- May 1, 2007
- Completion date
- August 9, 2008
- Enrollment
- 15 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma